Literature DB >> 30396965

Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis.

Masakuni Sakaguchi1, Toshiya Maebayashi2, Takuya Aizawa2, Naoya Ishibashi2.   

Abstract

AIM: To evaluate outcomes of breast cancer patients with confirmed dural metastasis (DM) alone who received whole-brain radiation therapy (WBRT). PATIENTS AND METHODS: The medical records of thirty-three breast cancer patients who received WBRT to treat intracranial metastasis were retrospectively reviewed. The clinical presentation of DM-only was compared with that of brain metastasis (BM)/leptomeningeal metastasis (LM).
RESULTS: Eight patients had DM and 25 patients had BM/LM. Median survival was 12 months in patients with DM and 7 months in those with BM/LM. Multivariate analysis found that only a Karnofsky performance status of ≥70 was significantly associated with improved OS. DM did not cause the death of any patient. Symptoms did not worsen in any DM patient.
CONCLUSION: WBRT can be considered for patients with DM alone for symptom improvement and preventing DM-related death. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Dural metastasis; brain metastasis; leptomeningeal metastasis; whole brain radiation therapy

Mesh:

Year:  2018        PMID: 30396965     DOI: 10.21873/anticanres.13001

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Rapid Progression of Intracranial Dural Metastases in a Patient with Carcinoma of Unknown Primary Site.

Authors:  Hiroyuki Takeda; Rintaro Ohe; Tadahisa Fukui; Shuhei Suzuki; Sho Nakamura; Kaname Watanabe; Takashi Yoshioka
Journal:  Case Rep Oncol       Date:  2019-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.